Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$107M Buy
318,926
+1,525
+0.5% +$484K 0.16% 115
2026
Q1
$79.5M Buy
317,401
+17,420
+6% +$3.87M 0.13% 146
2025
Q4
$48.6M Buy
299,981
+26,055
+10% +$4.52M 0.08% 222
2025
Q3
$41.3M Buy
273,926
+2,734
+1% +$365K 0.08% 245
2025
Q2
$34.8M Buy
271,192
+257,534
+1,886% +$25M 0.07% 258
2025
Q1
$986K Sell
13,658
-98
-0.7% -$10.4K ﹤0.01% 618
2024
Q4
$1.56M Sell
13,756
-221,036
-94% -$26.2M ﹤0.01% 608
2024
Q3
$23.4M Buy
234,792
+19,015
+9% +$1.58M 0.06% 319
2024
Q2
$18.7M Sell
215,777
-1,845
-0.8% -$168K 0.05% 360
2024
Q1
$17.8M Sell
217,622
-46,087
-17% -$2.9M 0.06% 361
2023
Q4
$12.7M Buy
+263,709
New +$11.2M 0.05% 415

Other funds holding VRT

Aviva's VRT Position: Q2 2026 in Review

Aviva increased its Vertiv (VRT) stake by 0.48% in Q2 2026, buying an estimated $484K and bringing the position to 318,926 shares worth $107M. The position accounts for 0.16% of the portfolio, ranked #115.

Aviva first reported a position in VRT in Q4 2023 and has held it in 11 quarters since. 2,049 funds tracked by Wall St. Rank hold VRT as of Q2 2026.

  • Aviva held 318,926 shares of Vertiv worth $107M as of Q2 2026.
  • Aviva bought 1,525 Vertiv shares in Q2 2026, an estimated $484K.
  • Vertiv made up 0.16% of Aviva's portfolio in Q2 2026, its #115 holding.
  • Aviva first reported a position in Vertiv in Q4 2023 and has held it in 11 quarters since.
  • 2,049 funds tracked by Wall St. Rank held Vertiv as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.